Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines

Molecular Carcinogenesis

Volumn 29, Issue 4, 2000, Pages 219-228

  Cui, Wei ^a   Yazlovitskaya, Eugenia M ^a   Mayo, Matthew S ^b   Pelling, Jill C ^a,b   Persons, Diane L ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

c Jun N terminal kinase; Cisplatin; Extracellular signal regulated kinase; Mitogen activated protein kinase; Ovarian carcinoma

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CARCINOMA CELL; CELL PROTECTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034526814     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D     Document Type: Article

References (43)

1. Drugs five years later. Cisplatin
2. Separation and characterization of products resulting from the reaction of cis-diammine-dichloroplatinum (II) with deoxyribonucleosides
3. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II)
4. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
5. Enhanced DNA repair as a mechanism of resistance to cis-diammine-dichloroplatinum (II)
6. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer
7. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
8. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line
9. Cis-diammine-dichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells
10. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation
11. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer cells
12. Overexpression of metallothionein confers resistance to anticancer drugs
13. Characterization of a cis-diamminedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
14. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines
15. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
16. Differential effects of UV-B and UV-C components of solar radiation on MAP kinase signal transduction pathways in epidermal keratinocytes
17. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation
18. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in radiation-induced apoptosis
19. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
20. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms
21. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling
22. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents
23. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin
24. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin
25. Cisplatin induced a persistent activation of JNK that is related to cell death
26. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
27. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin
28. How MAP kinases are regulated
29. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
30. Regulation and function of the JNK subgroup of MAP kinases
31. The MAPK signaling cascade
32. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signaling pathways on cell survival
33. Oxidative stress activates the human histidine decarboxylase promoter in AGS astric cancer cells
34. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis
35. Conformation-dependent phosphorylation of p53
36. MAPK activation determines renal epithelial cell survival during oxidative injury
37. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2
38. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor α-resistant ovarian carcinoma cell line UCl 101
39. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
40. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian cancer cell lines by buthionine mediated glutathione depletion
41. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines
42. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
43. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents